Paul TheisenPatient Acquisition
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Brenda SnowAuthentic Patient Voice
Bud BilanichSuccess Coach
Matt TurnerPatient Affordability
Liz KaneImpactful Strategy
Pat PurcellMeeting Engagement
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
Amy GilesIncreasing Engagement
Joey CohenMedication Adherence
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
40 percent of evaluable patients achieved survival of more than 12 months, 30 percent ...
Demcizumab and Tarextumab Randomized Phase 2 Data Expected 1H 2017 Anti-TIGIT IND Accepted; GITRL-Fc ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email